SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Coastlands Capital Files Schedule 13G for Kalaris Therapeutics

A Schedule 13G filing identifies Coastlands Capital LP as the filer for Kalaris Therapeutics.

Related stories